Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India

International Journal of Antimicrobial Agents

Volumn 31, Issue 4, 2008, Pages 387-389

  Dutta, Shanta ^a   Sur, Dipika ^a   Manna, Byomkesh ^a   Sen, Bhaswati ^a   Bhattacharya, Manjira ^a   Bhattacharya, Sujit Kumar ^a   Wain, John ^b   Nair, Satheesh ^b   Clemens, John D ^c   Ochiai, R Leon ^c  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; AZTREONAM; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; NALIDIXIC ACID; OFLOXACIN; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DISEASE SURVEILLANCE; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; INDIA; LETTER; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHI; TYPHOID FEVER;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FLUOROQUINOLONES; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; POPULATION SURVEILLANCE; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 40949102619     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.12.004     Document Type: Letter

References (11)

1. Bhan M.K., Bahl R., and Bhatnagar S. Typhoid and paratyphoid fever. Lancet 366 (2005) 749-762
2. Bhutta Z.A. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 333 (2006) 78-82
3. Threlfall E.J., Ward L.R., Rowe B., et al. Widespread occurrence of multiple drug-resistant Salmonella typhi in India. Eur J Clin Microbiol Infect Dis 11 (1992) 990-993
4. Rupali P., Abraham O.C., Jesudason M.V., John T.J., Zachariah A., Sivaram S., et al. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Microbiol Infect Dis 49 (2004) 1-3
5. Renuka K., Sood S., Das B.K., and Kapil A. High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 54 (2005) 999-1000
6. Ahmed D., D'Costa L.T., Alam K., Nair G.B., and Hossain M.A. Multidrug-resistant Salmonella enterica serovar Typhi isolates with high-level resistance to ciprofloxacin in Dhaka. Bangladesh. Antimicrob Agents Chemother 50 (2006) 3516-3517
7. Murdoch D.A., Banatvala N.A., Bone A., Shoismatulloev B.I., Ward L.R., and Threlfall E.J. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 351 (1998) 339
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. Document M100-S14. Wayne, PA: CLSI; 2004.
9. Kubota K., Barrett T.J., Ackers M.L., Brachman P.S., and Mintz E.D. Analysis of Salmonella enterica serotype Typhi pulsed-field gel electrophoresis patterns associated with international travel. J Clin Microbiol 43 (2005) 1205-1209
10. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
11. Turner A.K., Nair S., and Wain J. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother 58 (2006) 733-740